It's amazing how many ailments are tied to excessive inflammation which is why I also suggested Ebola as a potential target last night. Ebola likely wouldn't be as lucrative as hypertension and atherosclerosis but why stop there? Hantavirus? Life threatening allergies?

I could see a leronimab/rheumatoid arthritis trial at some point in the future too. That could be huge.